Tabula Rasa HealthCare Inc (NASDAQ:TRHC) Director Glen R. Bressner purchased 8,500 shares of the stock in a transaction that occurred on Tuesday, October 4th. The stock was purchased at an average price of $12.00 per share, for a total transaction of $102,000.00. Following the acquisition, the director now owns 2,793,932 shares in the company, valued at $33,527,184. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) opened at 13.45 on Thursday. The company has a 50 day moving average price of $14.42 and a 200-day moving average price of $14.42. Tabula Rasa HealthCare Inc has a 12-month low of $13.16 and a 12-month high of $16.17.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Receive News & Ratings for Tabula Rasa HealthCare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare Inc and related companies with MarketBeat.com's FREE daily email newsletter.